San Diego

4365 Executive Drive
Suite 1500
San Diego, CA 92121
(858) 926-3000
(858) 926-3001
  • Qualigen Closes Reverse Merger with Ritter Pharmaceuticals

    Stradling client Qualigen, Inc. completed its “reverse merger” transaction with Nasdaq-listed Ritter Pharmaceuticals, Inc. pursuant to an Agreement and Plan of Merger dated January 15. In connection with the closing, Ritter Pharmaceuticals was renamed Qualigen Therapeutics, Inc. and is proceeding forward as a Stradling public-company client, with Qualigen, a wholly-owned subsidiary of Qualigen Therapeutics.